Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;23(8):1082-1093.
doi: 10.1111/ner.13255. Epub 2020 Aug 24.

Stimulation Parameters for Sacral Neuromodulation on Lower Urinary Tract and Bowel Dysfunction-Related Clinical Outcome: A Systematic Review

Roman Assmann  1   2 , Perla Douven  1   2   3   4 , Jos Kleijnen  5 , Gommert A van Koeveringe  2   3 , Elbert A Joosten  2   4 , Jarno Melenhorst  1 , Stephanie O Breukink  1   2
Affiliations

Stimulation Parameters for Sacral Neuromodulation on Lower Urinary Tract and Bowel Dysfunction-Related Clinical Outcome: A Systematic Review

Roman Assmann et al. Neuromodulation. 2020 Dec.

Abstract

Objective: Sacral neuromodulation (SNM) has been used to treat patients with lower urinary tract dysfunction and bowel dysfunction for many years. Success rates vary between 50% and 80%, indicating that there is much room for improvement. Altering stimulation parameters may result in improved outcome. This paper reports a systematic review of the clinical efficacy of nonconventional stimulation parameters on urinary tract and bowel dysfunction.

Materials and methods: Three databases were used for the literature search: Ovid (Medline, Embase) and PubMed. Papers were screened by two independent reviewers, who also extracted data from these papers. Clinical papers studying SNM stimulation parameters, that is, intermittent stimulation, frequency, pulse width, and amplitude, in urinary tract and bowel dysfunction were included. Quality of included papers was assessed using standardized guidelines.

Results: Out of 5659 screened papers, 17 papers, studying various stimulation parameters, were included. Overall quality of these papers differed greatly, as some showed no risk of bias, whereas others showed high risk of bias. Stimulation parameters included intermittent stimulation, frequency, pulse width, amplitude, and unilateral vs. bilateral stimulation. Especially high frequency SNM and either a narrow or wide pulse width seem to improve efficacy in patients with bowel dysfunction. Additionally, implementation of short cycling intervals is promising to improve quality of life for patients with urinary tract or bowel dysfunction.

Conclusion: The results of our systematic review indicate that stimulation parameters may improve efficacy of SNM in treatment of both urinary tract dysfunction and bowel dysfunction.

Keywords: Fecal incontinence; sacral nerve stimulation; stimulation paradigm; voiding dysfunction.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of the included studies. [Color figure can be viewed at wileyonlinelibrary.com]
See this image and copyright information in PMC

References

    1. Moore CK, Rueb JJ, Derisavifard S. What is new in neuromodulation? Curr Urol Rep 2019;20:55. - PubMed
    1. Janssen PTJ, Kuiper SZ, Stassen LPS, Bouvy ND, Breukink SO, Melenhorst J. Fecal incontinence treated by sacral neuromodulation: long‐term follow‐up of 325 patients. Surgery 2017;161:1040–1048. - PubMed
    1. Peeters K, Sahai A, De Ridder D, Van Der Aa F. Long‐term follow‐up of sacral neuromodulation for lower urinary tract dysfunction. BJU Int 2014;113:789–794. - PubMed
    1. Marcelissen TAT, Leong RK, de Bie RA, van Kerrebroeck PEV, de Wachter SGG. Long‐term results of sacral neuromodulation with the tined lead procedure. J Urol 2010;184:1997–2000. - PubMed
    1. Siegel S, Noblett K, Mangel J et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6‐months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn 2015;34:224–230. - PubMed

Publication types